| Literature DB >> 15510217 |
Sylvain Pradervand1, Hideo Yasukawa, Olivier G Muller, Harald Kjekshus, Tomoyuki Nakamura, Tara R St Amand, Toshitaka Yajima, Kiyoyuki Matsumura, Hervé Duplain, Mitsuo Iwatate, Sarah Woodard, Thierry Pedrazzini, John Ross, Dmitri Firsov, Bernard C Rossier, Masahiko Hoshijima, Kenneth R Chien.
Abstract
The interleukin-6 cytokines, acting via gp130 receptor pathways, play a pivotal role in the reduction of cardiac injury induced by mechanical stress or ischemia and in promoting subsequent adaptive remodeling of the heart. We have now identified the small proline-rich repeat proteins (SPRR) 1A and 2A as downstream targets of gp130 signaling that are strongly induced in cardiomyocytes responding to biomechanical/ischemic stress. Upregulation of SPRR1A and 2A was markedly reduced in the gp130 cardiomyocyte-restricted knockout mice. In cardiomyocytes, MEK1/2 inhibitors prevented SPRR1A upregulation by gp130 cytokines. Furthermore, binding of NF-IL6 (C/EBPbeta) and c-Jun to the SPRR1A promoter was observed after CT-1 stimulation. Histological analysis revealed that SPRR1A induction after mechanical stress of pressure overload was restricted to myocytes surrounding piecemeal necrotic lesions. A similar expression pattern was found in postinfarcted rat hearts. Both in vitro and in vivo ectopic overexpression of SPRR1A protected cardiomyocytes against ischemic injury. Thus, this study identifies SPRR1A as a novel stress-inducible downstream mediator of gp130 cytokines in cardiomyocytes and documents its cardioprotective effect against ischemic stress.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15510217 PMCID: PMC526469 DOI: 10.1038/sj.emboj.7600454
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598